Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α-Synuclein
Viewpoint with my clinical colleague’s professor Michael G. Schlossmacher and professor Leonidas Stefanis where we discuss the two recent clinical anti-alpha-synuclein vaccination trials and possible ways to move forward.
![](/fileadmin/_processed_/f/6/csm_512x512bb-300x300_820d10ee70.jpg)